Rx/reimbursement adult incontinence is expected to see continued growth over the forecast period as the category continues to benefit from a rise in the number of consumers suffering incontinence. This will result from an increase in the size of the population aged 65 and over and growing consumer awareness of incontinence as a condition, which will encourage sufferers to address the problem sooner rather than later.
Despite expected growth, the Rx/reimbursement adult incontinence category is expected to face challenges during the forecast period. Health insurance companies’ ongoing efforts to reduce expenditure on Rx/reimbursement adult incontinence could temper the development potential of the category somewhat, as could further legislative changes requiring some users to cover a higher percentage of the cost of these products.
The introduction of electronic reimbursement will help local consumers unable to visit doctors to have adult incontinence products prescribed online, which they could then pick up in pharmacies. This is set to boost demand for prescribed adult incontinence products.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Czech Republic with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Czech Republic, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See All of Our DefinitionsThis report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!